Close

PerkinElmer unveils ChemBioOffice Version 13.0

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

McKesson Acquires Controlling Stake in PRISM Vision

McKesson Corporation has announced its agreement to acquire a...

CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review

CluePoints continues to transform clinical trial review and leverage its...

ML And AI Transforming Pharmaceutical R&D And Drug Discovery

Richard Lee, Director, Core Technology and Capabilities, ACD/Labs, says...

TraceLink’s Magnum Release of Platform for Supply Chain Management

TraceLink, the largest end-to-end digital network platform for intelligent...

PerkinElmer has launched the latest version of ChemBioOffice Informatics Suite to accelerate the discovery process through increased productivity and data sharing.

Version 13.0 adds improvements to the ChemBioDraw and ChemBio3D modules while providing secure cloud storage for improved data sharing.

The ChemBioOffice suite helps chemists and biologists to track their work and provides individual scientists within an organization the tools they need to create publication-ready drawings of compounds, reactions, materials and their properties for use in electronic laboratory notebooks and databases as well as for querying chemical databases.

PerkinElmer Informatics general manager Michael Stapleton said, “We are very excited to provide chemists and biologists with the new ChemBioOffice Suite, a premium tool developed to help scientists turn data into actionable information and make decisions with greater confidence, thereby accelerating their discovery process.”

The improved biopolymer toolbar of the ChemBioDraw program allows fast modifications to larger therapeutic agents and molecular structures such as amino acids, peptides, RNA, DNA and nucleotides.

With the ChemBio3D program, synthetic chemists and biologists will be able to generate 3D models and assess the shape and properties of small molecules and biochemical compounds.

The ChemBio3D program, which provides access to other computational and molecular modeling programs, can evaluate data input and provide important information such as the degree of fit of compounds into a receptor.

Latest stories